Angiodynamic Inc logo

ANGO

Angiodynamic Inc

$23.47

Earnings Summary

Revenue
$87Mn
Net Profits
$-6.27Mn
Net Profit Margins
-7.2%

Highlights

Revenue:

Angiodynamic Inc’s revenue jumped 13.22% since last year same period to $87Mn in the Q2 2022. On a quarterly growth basis, Angiodynamic Inc has generated 17.61% jump in its revenue since last 3-months.

Net Profits:

Angiodynamic Inc’s net profit jumped 67.81% since last year same period to $-6.27Mn in the Q2 2022. On a quarterly growth basis, Angiodynamic Inc has generated -26.38% fall in its net profits since last 3-months.

Net Profit Margins:

Angiodynamic Inc’s net profit margin jumped 71.57% since last year same period to -7.2% in the Q2 2022. On a quarterly growth basis, Angiodynamic Inc has generated -7.46% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Angiodynamic Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.02
EPS Estimate Current Year
-0.02

Highlights

EPS Estimate Current Quarter:

Angiodynamic Inc’s earning per share (EPS) estimates for the current quarter stand at -0.02 - a -300% fall from last quarter’s estimates.

EPS Estimate Current Year:

Angiodynamic Inc’s earning per share (EPS) estimates for the current year stand at -0.02.

Key Ratios

Key ratios of the Angiodynamic Inc post its Q2 2022 earnings

Earning Per Share (EPS)
0.01

Highlights

Earning Per Share (EPS):

Angiodynamic Inc’s earning per share (EPS) jumped 101.98% since last year same period to 0.01 in the Q2 2022. This indicates that the Angiodynamic Inc has generated 101.98% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-22
0.01
0.01
0%
2022-04-07
-0.01
0.03
400%

Company Information

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products.

Organisation
Angiodynamic Inc
Headquarters
Latham, New York, US
Employees
800
Industry
Health Technology
CEO
James Clemmer